Old Web
English
Sign In
Acemap
>
authorDetail
>
Subhramanyam Vangala
Subhramanyam Vangala
Tyrosine kinase
Tyrosine-kinase inhibitor
Lapatinib
Cancer research
Sitravatinib
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tyrosine Kinase Inhibitor Family of Drugs as Prospective Targeted Therapy for COVID-19 Based on In Silico And 3D-Human Vascular Lung Model Studies
2021
bioRxiv
Shalini Saxena
Kranti Meher
Madhuri Rotella
Subhramanyam Vangala
Satish Chandran
Nikhil Malhotra
Ratnakar Palakodeti
Sreedhara Voleti
Uday Saxena
Show All
Source
Cite
Save
Citations (1)
Preparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 Receptor
2021
bioRxiv
Gopi Kadiyala
Subramanian Iyer
Kranti Meher
Subhramanyam Vangala
Satish Chandran
Uday Saxena
Show All
Source
Cite
Save
Citations (0)
1